Loading...
Loading...
Biomet, Inc. announced today the commencement of a tender offer (“Tender
Offer”) to purchase for cash any and all of its 10% Senior Notes due 2017
(CUSIP Nos. 090613AC4; 550785AA7; U55004AA0) (the “Senior Notes”) and up to
$500 million of its outstanding 11 5/8% Senior Subordinated Notes due 2017
(CUSIP Nos. 090613AE0; 550785AE9; U55004AC6) (the “Senior Subordinated Notes”
and, together with the Senior Notes, the “Notes”).
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in